Dyslipidemia educational videosThree short online videos highlight key points in 2009 Canadian dyslipidemia guidelines. Eliquis: third new oral anticoagulant in CanadaIt is the third new oral anticoagulant to reach the Canadian market, joining rivaroxaban and dabigatran etexilate. Birth control formulation linked to elevated VTE risk Yaz, Yasmin contain drospirenone Weight loss leads to lasting benefits in heart function Study involving obese patients points to usefulness of imaging in monitoring results of various treatments Bioresorbable stent shows promise in North American trial Quebec woman recovering well two months after scaffold implanted Xarelto approved for stroke prevention in atrial fibrillation Drug was previously indicated only for the prevention of venous thromboembolic events. Resting heart rate increase linked to higher risk of heart disease death Home AFib detection Statins turn off bad clotting Apixaban less effective than enoxaparin in preventing VTE But problems with study design may have undermined results, researchers note Colchicine reduces postoperative atrial fibrillation But larger trials over longer period needed, lead researcher warns Counsel patients on correct method for Epipen use Pfizer and Health Canada remind healthcare professionals, consumers of the correct method for using EpiPen, EpiPen Jr. First Previous 63 64 65 66 67 Next Last
